|
시장보고서
상품코드
2050723
비침습적 산전 검사(NIPT) 시장 : 제품 및 서비스별, 용도별, 기술별, 기간별, 최종사용자별, 지역별Non-Invasive Prenatal Testing (NIPT) Market, By Product & Service, By Application, By Technology, By Period, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
비침습적 산전 검사(NIPT) 시장은 2026년에 56억 2,000만 달러로 추정되고, 2033년까지 113억 7,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 10.6%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 56억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.60% | 2033년 시장 규모 예측 : | 113억 7,000만 달러 |
세계 비침습적 산전검사(NIPT) 시장은 임신과 태아에 대한 침습 없이 산모의 혈류 내 태아 DNA를 검사하여 태아가 유전적 이상 위험이 높은지 여부를 확인하는 데 활용되고 있습니다. 이 검사에서는 모체의 혈류를 순환하는 태반 유래 세포 유리 DNA(cfDNA)를 분석합니다. 다운증후군, 13번 삼염색체, 18번 삼염색체, 성염색체 수 이상, 기타 이상과 같은 유전성 질환의 위험을 검사할 수 있습니다. 유전체 기술의 발전과 함께 NIPT는 정확한 결과를 제공하고 양수 천자와 같은 침습적 검사에 따른 유산의 위험을 피할 수 있어 전 세계 임산부들 사이에서 선구적인 산전 선별 검사로 각광받고 있습니다.
시장 역학
세계 비침습적 산전검사(NIPT) 시장은 임산부의 고령화, 다운증후군 출생률 증가, NIPT에 대한 인식 증가, 진단 도구의 기술 발전 등의 요인에 의해 주도되고 있습니다. 그러나 저소득 국가의 진단 서비스 접근성 제한과 낙태와 관련된 윤리적 문제가 시장 성장을 저해하고 있습니다. 큰 기회로는 개발도상국의 미개척 시장과 유전자 돌연변이 및 염색체 미세결실 및 중복을 검출하기 위한 NIPT의 적용 범위를 확대하기 위한 지속적인 연구개발을 꼽을 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 세계 비침습적 산전 검사(NIPT) 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 비침습적 산전 검사(NIPT) 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가를 포함한 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 비침습적 산전검사(NIPT) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 비침습적 산전 검사(NIPT) 시장 : 제품 및 서비스별, 2021년-2033년
제5장 세계의 비침습적 산전 검사(NIPT) 시장 : 용도별, 2021년-2033년
제6장 세계의 비침습적 산전 검사(NIPT) 시장 : 기술별, 2021년-2033년
제7장 세계의 비침습적 산전 검사(NIPT) 시장 : 기간별, 2021년-2033년
제8장 세계의 비침습적 산전 검사(NIPT) 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 비침습적 산전 검사(NIPT) 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.06.12Non-Invasive Prenatal Testing (NIPT) Market is estimated to be valued at USD 5.62 Bn in 2026 and is expected to reach USD 11.37 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.62 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.60% | 2033 Value Projection: | USD 11.37 Bn |
Global Non invasive Prenatal Testing (NIPT) Market is used to screen fetal DNA in the mother's bloodstream to check if the fetus is at a high risk of genetic abnormalities without being invasive to the pregnancy or the fetus. These tests analyze cell free DNA (cfDNA) from the placenta that circulates in the mother's bloodstream. They can check the risk of genetic conditions like Down's syndrome, Trisomy 13, Trisomy 18, sex chromosome aneuploidies, and other abnormalities. With advancements in genomic technologies, NIPT has become one of the pioneering techniques used for prenatal screening and is gaining immense popularity among expectant mothers worldwide as it provides accurate results and avoids risks of miscarriage associated with invasive tests like amniocentesis.
Market Dynamics
The global Non invasive Prenatal Testing (NIPT) market is driven by factors such as increasing maternal age, rising incidence of babies born with Down's syndrome, growing awareness about NIPT, and technological advancements in diagnostic tools. However, limited access to diagnostic services in low income countries and ethical issues related to abortion restrain market growth. Significant opportunities include untapped markets in developing countries and ongoing R&D to expand applications of NIPT to detect genetic mutations and chromosomal microdeletion or duplications.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global Non invasive Prenatal Testing (NIPT) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Illumina, Inc., Natera, Inc., Roche Diagnostics, Ariosa Diagnostics, Verinata Health, Inc., Yourgene Health, Centogene N.V., Eurofins Scientific, F. Hoffmann La Roche Ltd., LabCorp, Quest Diagnostics, BGI Genomics, MedGenome Labs, Genetic Technologies Limited, and Myriad Genetics, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics.
- The global Non invasive Prenatal Testing (NIPT) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global Non invasive Prenatal Testing (NIPT) market.
Market Segmentation
- By Product & Service Insights (Revenue, USD Bn, 2021 - 2033)
- Product
- Consumables
- Assay Kits and Reagents
- Instruments
- Services
- By Application Insights (Revenue, USD Bn, 2021 - 2033)
- Trisomy Detection
- Microdeletion Detection
- Sex Chromosome Aneuploidy Detection
- By Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Array Technology
- Rolling Circular Amplification
- By Period Insights (Revenue, USD Bn, 2021 - 2033)
- 0-12 Weeks
- 13-24 Weeks
- 25-36 Weeks
- By End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Illumina, Inc.
- Natera, Inc.
- Roche Diagnostics
- Ariosa Diagnostics
- Verinata Health, Inc.
- Yourgene Health
- Centogene N.V.
- Eurofins Scientific
- Hoffmann-La Roche Ltd.
- LabCorp
- Quest Diagnostics
- BGI Genomics
- MedGenome Labs
- Genetic Technologies Limited
- Myriad Genetics, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Non-invasive Prenatal Testing (NIPT) Market, By Product & Service
- Global Non-invasive Prenatal Testing (NIPT) Market, By Application
- Global Non-invasive Prenatal Testing (NIPT) Market, By Technology
- Global Non-invasive Prenatal Testing (NIPT) Market, By Period
- Global Non-invasive Prenatal Testing (NIPT) Market, By End User
- Global Non-invasive Prenatal Testing (NIPT) Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Non-invasive Prenatal Testing (NIPT) Market, By Product & Service, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Product
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Consumables
- Assay Kits and Reagents
- Instruments
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Non-invasive Prenatal Testing (NIPT) Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Trisomy Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microdeletion Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sex Chromosome Aneuploidy Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Non-invasive Prenatal Testing (NIPT) Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Array Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Rolling Circular Amplification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Non-invasive Prenatal Testing (NIPT) Market, By Period, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- 0-12 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 13-24 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 25-36 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Non-invasive Prenatal Testing (NIPT) Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Non-invasive Prenatal Testing (NIPT) Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Period, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Period, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Period , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Period , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Period , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Period, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Natera, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ariosa Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Verinata Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Yourgene Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Centogene N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LabCorp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MedGenome Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genetic Technologies Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
